Product Description
Rimantadine is used to prevent and treat infections caused by influenza A virus. (Sourced from: https://medlineplus.gov/druginfo/meds/a698029.html)
Mechanisms of Action: DNA Replication Inhibitor,Matrix2 Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: None *
Approval Status: Approved
Approved Countries: Bulgaria | China | Dominican Republic | Egypt | Latvia | Lithuania | Mexico | Poland | Russia | Ukraine | United States
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|